DTT Journal & Abstracts
Diabetes Technology & Therapeutics
Diabetes Technology & Therapeutics is the official journal of ATTD.
Led by Editor-in-Chief Satish K. Garg, MD, Diabetes Technology & Therapeutics is the only peer-reviewed journal providing information on new devices, drugs, drug delivery systems and software for managing patients with diabetes.
This leading international journal delivers practical information and comprehensive coverage of the latest technologies and therapeutics in the field. Each issue highlights new pharmacological and device developments to optimize patient care.
- To view the ATTD 2025 Abstracts published in the DTT Journal, click here.
Abstracts published at previous ATTD Conferences:
- To view the ATTD 2024 Abstracts published in the DTT Journal, click here.
- To view the ATTD 2023 Abstracts published in the DTT Journal, click here.
- To view the ATTD 2022 Abstracts published in the DTT Journal, click here.
- To view the ATTD 2021 Abstracts published in the DTT Journal, click here.
- To view the ATTD 2020 Abstracts published in the DTT Journal, click here.
- To view the ATTD 2019 Abstracts published in the DTT Journal, click here.
- To view the ATTD 2018 Abstracts published in the DTT Journal, click here.
- To view the ATTD 2017 Abstracts published in the DTT Journal, click here.
- To view the ATTD 2016 Abstracts published in the DTT Journal, click here.
- To view the ATTD 2015 Abstracts published in the DTT Journal, click here.
- To view the ATTD 2014 Abstracts published in the DTT Journal, click here.
Special Subscription Rates for ATTD Attendees
Save over 50% on your personal online subscription!
Visit the DTT website and enter group code ATTD.
